NZQA Expiring unit standard
25265 version 2
Page 1 of 4
Title
Demonstrate knowledge of human immune system and malignant
disease and medicines used in their treatment
Level
5
Purpose
Credits
8
This unit standard is intended for pharmacy technicians or
people working towards a pharmacy technician qualification.
People credited with this unit standard are able to demonstrate
knowledge of: the structure and function of the immune system;
immune disorders and medicines used in their treatment; and
malignant diseases and medicines used in their treatment.
Classification
Pharmacy > Pharmacy Services
Available grade
Achieved
Entry information
Critical health and
safety prerequisites
Open.
Explanatory notes
This unit standard is
expiring
Legislation, codes, and standards relevant to this unit standard include:
Pharmacy technicians must act within the legislative limits of their role as specified by the
Medicines Regulations 1984 and must always act under the supervision of a
pharmacist and under the direct personal supervision of a pharmacist when
dispensing or compounding.
2
Consumer Guarantees Act 1993;
Fair Trading Act 1986;
Hazardous Substances and New Organisms Act 1996;
Health and Disability Commissioner (Code of Health and Disability Services Consumers’
Rights) Regulations 1996;
Code of Health and Disability Services Consumers’ Rights, available from the Health and
Disability Commissioner’s office;
Health Information Privacy Code 1994, available from the Privacy Commissioner’s office;
Health (Retention of Health Information) Regulations 1996;
Health (Needles and Syringes) Regulations 1998;
Health and Safety in Employment Act 1992;
Health and Safety in Employment Regulations 1995;
Medicines Act 1981;
Medicines Regulations 1984;
Misuse of Drugs Act 1975;
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016
NZQA Expiring unit standard
25265 version 2
Page 2 of 4
Privacy Act 1993;
Misuse of Drugs Regulations 1977; and any subsequent amendments.
National Immunisation Schedule, available from the Ministry of Health;
New Zealand Code of Good Manufacturing Practice for Manufacture and Distribution of
Therapeutic Goods, Part 3 Compounding and Dispensing (1993), available from
Medsafe;
The New Zealand Pharmaceutical Schedule, available from http://www.pharmac.govt.nz;
Pharmacy Council of New Zealand Code of Ethics 2004, available at
http://www.pharmacycouncil.org.nz.
3
Access to appropriate reference resources in accordance with Medsafe audit
requirements is required for completion of assessment against this unit standard.
Evidence presented by the candidate must be in accordance with reference resources.
4
This unit standard is designed to cover knowledge sufficient to provide, under direct
personal supervision of a pharmacist, client counselling when dispensed medicine is
handed out.
The Pharmacy Council advises the public that before leaving the pharmacy they will
receive counselling that confirms and explains:
who the medicine is for
what the medicine is for
the directions for proper use and what special precautions to take
foods or medicines to avoid
common side effects or interactions, what to expect and how to treat, if needed
how soon to expect the medicine to work
what to do if you miss a dose
how to store your medicine and dispose of unused medicines safely
if there are repeats or a balance owing and how and when to collect them.
This information is available on the Pharmacy Council website:
www.pharmacycouncil.org.nz.
This unit standard is
expiring
Immune disorders include but are not limited to – allergies and over-reaction of the
immune system, auto-immune disorders, HIV/AIDS, chemotherapy-induced
immunosuppression.
Sites of malignant diseases may include but are not limited to – blood cells, bowel, brain,
breast, colon, lung, skin, reproductive system.
5
Outcomes and evidence requirements
Outcome 1
Demonstrate knowledge of the structure and function of the immune system.
Evidence requirements
1.1
The location and structure of parts of the immune system are identified and
explained in terms of their function.
Range
includes but is not limited to – specific and non-specific defence
mechanisms.
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016
NZQA Expiring unit standard
25265 version 2
Page 3 of 4
1.2
The inflammatory response is explained in terms of the physiological processes
including chemical indicators.
1.3
The immune response is explained in terms of its mechanism.
Outcome 2
Demonstrate knowledge of immune disorders and medicines used in their treatment.
Range
medicines include but are not limited to – adrenaline, antihistamines,
immunoglobulins, immunomodifiers, immunosuppressants.
Evidence requirements
2.1
Immune disorders and their signs and symptoms are identified and explained in
terms of the effects on body functions.
2.2
Medicines are identified according to their use for treatment of immune
disorders and therapeutic manipulation of immune function.
2.3
Actions and limitations of the medicines are identified and explained in terms of
their effect on body functions.
Range
2.4
may include but is not limited to – cautions, contra-indications,
clinically significant adverse effects, drug interactions.
Type of advice required by the Pharmacy Council for pharmacy clients is
identified
Range
evidence is required for a minimum of one treatment for an
immune disorder.
This unit standard is
Demonstrate knowledge of malignant
diseases and medicines used in their treatment.
expiring
Outcome 3
Range
medicines include but are not limited to – cytotoxics, drugs affecting immune
response, hormonal antineoplastics, adjunctive therapy.
Evidence requirements
3.1
Malignant disease is explained in terms of abnormalities of cell growth and
regulation as compared to normal cell growth and regulation.
3.2
Development of malignant disease is explained in terms of the physiological
process and role of genetic, lifestyle, and environmental factors.
3.3
Types of malignant disease and their signs and symptoms are identified and
explained in terms of their effects on body functions.
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016
NZQA Expiring unit standard
25265 version 2
Page 4 of 4
3.4
Medicines are identified according to their use for treatment of malignant
diseases.
3.5
Actions and limitations of the medicines are identified and explained in terms of
their effect on body functions.
may include but is not limited to – cautions, contra-indications,
clinically significant adverse effects, drug interactions.
Range
3.6
Type of advice required by the Pharmacy Council for pharmacy clients is
identified
Range
evidence is required for a minimum of one treatment for a
malignant disease.
This unit standard is expiring. Assessment against the standard must take place by
the last date for assessment set out below.
Status information and last date for assessment for superseded versions
Process
Version Date
Last Date for Assessment
Registration
1
21 November 2008
31 December 2017
Review
2
16 April 2015
31 December 2017
Consent and Moderation Requirements (CMR) reference
0128
This CMR can be accessed at http://www.nzqa.govt.nz/framework/search/index.do.
Please note
Providers must be granted consent to assess against standards (accredited) by NZQA,
before they can report credits from assessment against unit standards or deliver courses
of study leading to that assessment.
This unit standard is
Industry Training Organisations must
be granted consent to assess against standards by
expiring
NZQA before they can register credits from assessment against unit standards.
Providers and Industry Training Organisations, which have been granted consent and
which are assessing against unit standards must engage with the moderation system that
applies to those standards.
Requirements for consent to assess and an outline of the moderation system that applies
to this standard are outlined in the Consent and Moderation Requirements (CMR). The
CMR also includes useful information about special requirements for organisations wishing
to develop education and training programmes, such as minimum qualifications for tutors
and assessors, and special resource requirements.
Pharmacy Industry Training Organisation
SSB Code 102150
 New Zealand Qualifications Authority 2016